BNP Paribas Discount Zert ZURN 30.../ DE000PN7J5Y8 /
31/05/2024 09:20:29 | Var.+0.500 | Denaro09:28:09 | Lettera09:28:09 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
353.650EUR | +0.14% | 353.640 Quantità in denaro: 500 |
353.740 Quantità in lettera: 500 |
ZURICH INSURANCE N | - CHF | 30/12/2024 | Call |
Newsfile Corp
09:06
me88 Launches me scoreAI: Revolutionizing Football Predictions for UEFA Euro Cup 2024
Newsfile Corp
09:01
ReGen III Announces Closing of Initial Tranche of Convertible Debenture Offering
GlobeNewswire
09:00
insightsoftware to Strengthen xP&A and Write-Back Capabilities in Qlik With Fiplana Acquisition
GlobeNewswire
08:14
STMicroelectronics to build the world’s first fully integrated silicon carbide facility in Italy
GlobeNewswire
08:00
Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
GlobeNewswire
07:30
Baosheng Media Group Holdings Limited Announces Filing of Current Report on Form 6-K with the SEC re...
GlobeNewswire
07:05
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
GlobeNewswire
07:05
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
GlobeNewswire
07:00
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type ...